Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 1996Journal of Clinical InvestigationOpen Access

The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.

View Full Paper
Ask AI
Bookmark
Share

Authors

TMToshio MiyataToho UniversityOHOsamu HoriKanazawa UniversityJZJian ZhangSouth China Agricultural University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Miyata et al. (1996) studied this question.

synapsesocial.com/papers/6a7da86c968fa26fcacb4d10https://doi.org/10.1172/jci118889
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.1996 · 553 citations
  2. 2Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins1994 · 1,308 citations
  3. 3Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins.1991 · 194 citations
  4. 4Protein iodination with solid state lactoperoxidase1974 · 449 citations